Pricing Log in Create free account
Friday 6 November 2026 Export SNY’s income statement to Excel — free account

Sanofi

SNY Healthcare Drug Manufacturers General

Sanofi’s revenue for fiscal 2025 (year ended December 2025) was $52.9 billion, up 10.3% from fiscal 2024.

Revenue
+13.9%
EPS
+8.21%
Free cash flow
+99.6%
Total debt
−11.2%

Quarter to September 2026, against a year earlier

46.81 0.66 −1.39%
Market cap
$111.8B
P/E
23.2×
Fwd P/E
—
Dividend yield
5.18%
F-score
7/9
Altman Z
2.50
Beneish M
−2.63
Dividend safety
54/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Sanofi (SNY) P/S ratio

Alert me on P/S ratio

As of 5 November 2026, Sanofi (SNY) trades at a P/S ratio of 1.9×. Over the past ten years it has ranged from 1.5× (March 2020) to 3.3× (August 2015); the current reading is higher than 15% of that period. That is below the Drug Manufacturers General industry median of 3.5× and below the Healthcare sector median of 3.5×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 2.2× (11.16%)
FY2024 2.5× 1.16%
FY2023 2.5× (2.94%)
FY2022 2.6× 37.04%
FY2021 1.9× (1.94%)
FY2020 1.9× (6.19%)
FY2019 2.0× (1.11%)
FY2018 2.1× (22.66%)
FY2017 2.7× (3.17%)
FY2016 2.7× 6.04%

Quarterly newest first

Period P/S ratio Change
Sep 2026 1.7× (6.58%)
Jun 2026 1.8× (15.28%)
Mar 2026 2.1× (5.45%)
Dec 2025 2.2× (8.95%)
39 more quarters

Against its own ten years

Low 1.5× High 3.3×
Ten-year median 2.4×
Current reading's percentile 16

P/S ratio against peers

Company P/S ratio
SNY Sanofi 1.9×
GSK GSK PLC Sponsored ADR compare 2.2×
BMY Bristol Myers Squibb Company compare 2.6×
PFE Pfizer Inc. compare 2.7×
NVO Novo Nordisk A/S compare 3.5×
AZN AstraZeneca PLC compare 4.7×
NVS Novartis AG compare 5.4×
AMGN Amgen Inc. compare 6.4×
GILD Gilead Sciences, Inc. compare 6.7×
Drug Manufacturers General industry median 3.5×
Healthcare sector median 3.5×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on SNY